In Brief: Genetics Institute/Johns Hopkins
This article was originally published in The Gray Sheet
Executive Summary
Genetics Institute/Johns Hopkins: Form Metamorphix, Inc. to develop and commercialize transforming growth factor-beta (TGF~) genes, which are involved in cell growth and differentiation. GI, a unit of American Home Products, will contribute $3.6 mil. in exchange for 58% of the new company. GI is conducting pilot clinical trials on one type of TGF~ gene it discovered, bone morphogenic proteins, for treating tibia and maxillofacial bone fractures, and for use in spinal reconstruction. The latter trial is part of a four-year, $50 mil. collaboration with Sofamor Danek announced earlier this year ("The Gray Sheet" Feb. 20, I&W-2)...